Allogene Therapeutics, Inc. (ALLO)
1.48
+0.06
(+4.23%)
USD |
NASDAQ |
Dec 10, 16:00
1.47
-0.01
(-0.68%)
After-Hours: 20:00
Allogene Therapeutics Market Cap: 332.60M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Akero Therapeutics, Inc. | 4.499B |
| ANI Pharmaceuticals, Inc. | 1.842B |
| AIM ImmunoTech, Inc. | 1.116M |
| Protalix Biotherapeutics, Inc. | 146.37M |
| Armata Pharmaceuticals, Inc. | 213.98M |
Market Cap Related Metrics
| Price to Book Value | 1.055 |
| Price | 1.48 |
| Earnings Yield | -66.29% |